New Nordic Healthbrands Stock Cash Per Share
| NNH Stock | SEK 14.60 1.00 6.41% |
New Nordic Healthbrands fundamentals help investors to digest information that contributes to New Nordic's financial success or failures. It also enables traders to predict the movement of New Stock. The fundamental analysis module provides a way to measure New Nordic's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to New Nordic stock.
New |
New Nordic Healthbrands Company Cash Per Share Analysis
New Nordic's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Current New Nordic Cash Per Share | 3.16 X |
Most of New Nordic's fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, New Nordic Healthbrands is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
| Competition |
In accordance with the recently published financial statements, New Nordic Healthbrands has a Cash Per Share of 3.16 times. This is 27.36% lower than that of the Healthcare sector and 15.33% higher than that of the Drug Manufacturers - Specialty & Generic industry. The cash per share for all Sweden stocks is 36.93% higher than that of the company.
New Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses New Nordic's direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of New Nordic could also be used in its relative valuation, which is a method of valuing New Nordic by comparing valuation metrics of similar companies.New Nordic is currently under evaluation in cash per share category among its peers.
New Fundamentals
| Return On Equity | -0.0316 | |||
| Return On Asset | -0.0058 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | (0) % | |||
| Current Valuation | 221.83 M | |||
| Shares Outstanding | 6.2 M | |||
| Shares Owned By Insiders | 48.28 % | |||
| Price To Earning | 17.52 X | |||
| Price To Book | 1.56 X | |||
| Price To Sales | 0.36 X | |||
| Revenue | 514.85 M | |||
| Gross Profit | 350.05 M | |||
| EBITDA | 29.48 M | |||
| Net Income | 21.3 M | |||
| Cash And Equivalents | 11.88 M | |||
| Cash Per Share | 3.16 X | |||
| Total Debt | 1.24 M | |||
| Debt To Equity | 0.80 % | |||
| Current Ratio | 1.92 X | |||
| Book Value Per Share | 18.74 X | |||
| Cash Flow From Operations | (7.87 M) | |||
| Earnings Per Share | 1.91 X | |||
| Number Of Employees | 70 | |||
| Beta | 0.67 | |||
| Market Capitalization | 184.62 M | |||
| Total Asset | 238.35 M | |||
| Retained Earnings | 32 M | |||
| Working Capital | 32 M | |||
| Current Asset | 130 M | |||
| Current Liabilities | 98 M | |||
| Z Score | 91.4 | |||
| Annual Yield | 0.04 % | |||
| Net Asset | 238.35 M | |||
| Last Dividend Paid | 1.25 |
About New Nordic Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze New Nordic Healthbrands's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of New Nordic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of New Nordic Healthbrands based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for New Stock Analysis
When running New Nordic's price analysis, check to measure New Nordic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy New Nordic is operating at the current time. Most of New Nordic's value examination focuses on studying past and present price action to predict the probability of New Nordic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move New Nordic's price. Additionally, you may evaluate how the addition of New Nordic to your portfolios can decrease your overall portfolio volatility.